x
[quotes_form]
Enzymology

Enzymes as Biocatalysts

Biocatalysts refer to proteins that drive all non-spontaneous chemical reactions in any biological system.

Also known as enzymes, they are sensitive to temperature and pH, and act only on their specific reactants, unlike inorganic catalysts. However, their activities can be modulated and controlled. Since enzymes are also active in vitro and are organic in nature, they have been isolated, modified, and used in many industries. 

What Do Catalysts Do?

A non-spontaneous chemical reaction can only happen when the reactant molecules have obtained a sufficient amount of energy, termed activation energy. The sooner the reactants acquire the activation energy, the faster they can turn into their unstable transition state and begin to transform into (a) product(s).[1]

Thus, chemical reactions possessing high activation energy will require a tremendous amount of energy for their reactants to transform into products. In such cases, extra heat (thermal energy) or pressure (kinetic energy) is often applied so that the expected product(s) are generated in time.

Rather than putting in more energy to meet the activation energy, catalysts can be added to certain chemical reactions so that their activation energy is lowered. At the initiation of a catalyzed reaction, catalysts spontaneously interact with molecules of the reactants and encourage their transformation into products.

Towards the end of the reaction, catalysts are released from the catalyst-product complex and are reused in the next round. When the reaction reaches the reactant-product equilibrium, the amount of the catalyst that remains in the system is not different from the start of the reaction.[2]

In other words, catalysts guide the reactants to take a detour to avoid the high hill of activation energy. The detour is typically more complex, but the time it takes to reach the destination is far shorter.

Enzymes are Natural Catalysts with High Turnover Rate

Catalysts exist in many forms and are either readily available in nature or man-made. They can be in the same phase as the reactant (homogeneous catalysis) or a different phase (heterogeneous catalysis).[2] They can exist as small molecules such as ions, radicals, metal atoms, organometallic compounds and complexes, or as large and complex molecules like proteins, metal crystals or porous solid surfaces.[2,3]

Biocatalysts refer to enzymes, which are proteins that catalyze any chemical reaction that takes place in a living cell of any organism. Similar to inorganic catalysts, enzymes expedite the rate of chemical reactions by reducing the activation energy but at a higher turnover rate.

Because enzymes are fundamentally proteins that function in living organisms, most of their activities are optimal in the aqueous phase, in a condition that resembles the organism’s natural state, which is sensitive to changes in temperature and pH.[4]

Biocatalytic activity is specifically induced and inhibited

One of the most unique features of biocatalysts is the specificity in the initiation and inhibition of their catalytic activities. This unique feature stems from the three-dimensional structure of enzymes, which are built up from intramolecular interactions between the amino acid species that are assembled into proteins.

Most amino acids in enzymes contribute to their geometric form, while only a few serve as residues at the catalytic center.[5] Also known as the active site, the catalytic center is a small site on the enzyme where enzyme-reactant and enzyme-product interactions take place.[1,6]

The shape of the active site resembles a small pocket or a narrow channel, which allows only reactants, referred to as substrates, that are complementary to the active site to access. Thus, only the intended reactant(s) can interact with the functional residues at the active site to initiate the enzyme’s catalytic activity.[1,5,6]

Enzymes are said to be absolute specific when they recognize only a particular substrate and group-specific when they recognize molecules that have a specific functional group.[5]

Similar to the initiation of biocatalysis, enzymatic activity can be inhibited when a molecule with a similar conformation to the substrate competes with the substrate and successfully binds to the active site.[1]

Reactions catalyzed by biocatalysts can be regulated

Other than substrate specificity, the regulation of biocatalytic activity is another hallmark of biocatalysts. Again, this unique feature is also due to the structural dimension of proteins.

For example, certain enzymes may require interactions with a specific cofactor or coenzyme for their activity. When bound to a cofactor or coenzyme, the enzyme alters its structure into an active form so that catalytic activity can be achieved.

Along the same line, some enzymes can specifically bind to a small molecule, termed ligand, at their non-catalytic binding site, the allosteric site. Enzyme-ligand binding influences the enzyme conformation, which can result in catalytic enhancement if the ligand is an activator or the suppression of its catalytic activity if the ligand is an inhibitor.[6]       

The followings compare the main differences between enzymes and synthetic catalysts:

Biocatalysts Inorganic Catalysts
Natural enzymes/proteins
Non-enzymatic catalysts, e.g. ions, metal atoms, or solid surface
Sensitive to temperature and pH changes
Are less sensitive to temperature and pH change
Catalyze only when interacting with a specific reactant (substrate)
Catalyze various reactants
Can be specifically regulated
Cannot be regulated

Catalytic Mechanisms

Biocatalysts use one or more of the following mechanisms to catalyze chemical reactions:

1. Catalysis Through Proximity and Orientation Effects

Biocatalysts can facilitate enzymatic reactions when they form weak and transient bonds with their substrates.[6] The formation of an enzyme-substrate bond brings all substrates in the reaction into contact, especially if the reaction is composed of more than one.

The enzyme-substrate bond also arranges the substrates in the right order and in the orientation that they have the most reactive chirality.[1]

2. Acid-Base Catalysis

In acid-base catalysis, the functional group in the active site can act as catalytic acids or bases. As catalytic acids in a general acid catalyzed reaction, the enzyme’s catalytic group donates protons to the substrate, while in general base catalysis, the catalytic group receives protons from the substrate.

Both acid and base catalysis enhance the reactivity of the substrate functional group, stabilize the transition state and facilitate bond cleavage. Many enzymes contain many functional residues which act as acids at one site of the substrate and simultaneously as bases at another. Such acid-base catalysis is termed concerted acid-base catalysis.[1,6]

3. Covalent Catalysis

Also known as nucleophilic catalysis, covalent catalysis involves the formation of a transient covalent bond between the enzyme and its substrate. A nucleophilic group of the enzyme binds with an electrophilic group of the substrate, which results in an unstable enzyme-substrate complex that possesses an electrophilic catalytic center.

After the electrons are withdrawn from the substrate, it’s transformed into a product, and the covalent bond between the enzyme and product is eliminated.[1,6]

4. Metal Ion Catalysis

Metalloenzyme is a group of enzymes that predominantly use metal ion catalysis. They contain metal ion cofactors and are only active when they are bound to their cofactors.[1]  The positive charges in metal ions provide them with the ability to behave similarly to acids.

Nevertheless, metal ion charges can be higher than +1 and do not shift the pH of the system regardless of their concentration.[1,6] These characteristics allow metal ions to enhance the nucleophilicity of the system when they act as Lewis acids and accept electrons from the substrate even at neutral or basic pH.

Another way that metal ions participate in catalyzed reactions is to shield substrates or stabilize intermediates that are negatively charged. The shielding and stabilization of negatively charged species adjust the orientation and minimize any repulsing force from the substrates or intermediates.

As a result, the activation energy of the reaction is reduced, and the transformation of substrates to products is favored, or vice versa.[6]

5. Electrostatic Catalysis

The restricted shape of the enzyme active binding site creates an enclosed setting, to which only its complementary substrates and other highly similar molecules can gain access.

In electrostatic catalyzed reactions, the binding of the enzyme to its substrate brings about charge distribution around the active site, which stabilizes the transition state or the intermediates of the reaction.[6]

6. Preferential Binding of the Transition State Complex

In this type of catalysis, biocatalysts react more favorably to the transition state than their substrates or product(s). In essence, the enzymes have the highest affinity to the transition state, higher than compared to the substrates and products.

This drives the reaction towards an increase in the concentration of the transition state, which in turn enhances the rate of the catalyzed reaction.[1]

Examples of Biocatalysts Applications

Biocatalysts are active outside of living cells, given that all reaction components are present, and the temperature and pH condition is suitable for their catalytic activities. Due to enzyme specificity and high turnover rate, they have been applied across many industries. For instances: 

  • In consumer products, it’s estimated that the largest use of isolated enzymes goes to the use of ɑ-amylase and glucoamylase for the liquefaction and saccharification of starch. The two processes result in glucose, which is used as commodities in other products. For example, glucose is the substrate for glucose isomerase, which is used in the production of high-fructose corn syrup.[5,7]
  • In the pharmaceutical industry, the use of biocatalysts to acquire large-scale chiral compounds is one of the industry’s main focuses. Chirality is one of the essential determinants of whether a compound will be active or toxic. Since enzymes are specific by nature, they are capable of stereoselectivity. Lipases and transaminases are among the most frequently used biocatalysts to synthesize chiral compounds in the pharmaceutical industry. [5,8]
  • In research, one notable application of biocatalysts is in Polymerase Chain Reactions (PCR), regarded as the cornerstone of molecular biology. With PCR, millions of DNA fragments are synthesized in laboratories using DNA polymerase from the thermophilic bacteria, Thermus aquaticus. The technique has been credited as one of the breakthroughs that propel the biotechnology revolution.[1]

In Conclusion

All things considered; enzymes are similar to typical catalysts in that they expedite chemical reactions by redirecting them to the path with lower activation energy.

However, like proteins, enzymes are three dimensional ‘natural’ catalysts, whose structure affords them selectivity and regulatory means, unlike any inorganic catalyst.

Enzymes as biocatalysts are highly discriminatory, in terms of their reactants and products, and can catalyze complex reactions with a high turnover rate, which make them highly applicable in many industries. 

References

  1. Voet D, Voet JG and Pratt CW, Fundamentals of Biochemistry, 2nd edition. New Jersey: John Wiley & Sons; 2006.
  2. Chorkendorff I, Niemantsverdriet H. Introduction to Catalysis. In: Concepts of Modern Catalysis and Kinetics. 2nd ed. Weinheim: WILEY-VCH Verlag GmbH & Co.; 2007.
  3. Ye R, Zhao J, Wickemeyer BB, Toste FD, Somorjai GA. Foundations and strategies of the construction of hybrid catalysts for optimized performances. Nat Catal. 2018;1(5):318-325. doi:10.1038/s41929-018-0052-2
  4. van Schie MMCH, Spöring J-D, Bocola M, Domínguez de María P, Rother D. Applied biocatalysis beyond just buffers – from aqueous to unconventional media. Options and guidelines. Green Chem. 2021. doi:10.1039/D1GC00561H
  5. Sheldon RA, Brady D, Bode ML. The Hitchhiker’s guide to biocatalysis: recent advances in the use of enzymes in organic synthesis. Chem Sci. 2020;11(10):2587-2605. doi:10.1039/C9SC05746C
  6. Punekar NS. Hallmarks of an Enzyme Catalyst. In: ENZYMES: Catalysis, Kinetics and Mechanisms. Singapore: Springer Singapore; 2018:43-51. doi:10.1007/978-981-13-0785-0_5
  7. Carr ME, Black LT, Bagby MO. Continuous enzymatic liquefaction of starch for saccharification. Biotechnol Bioeng. 1982;24(11):2441-2449. doi:10.1002/bit.260241110
  8. Wu S, Snajdrova R, Moore JC, Baldenius K, Bornscheuer UT. Biocatalysis: Enzymatic Synthesis for Industrial Applications. Angew Chemie Int Ed. 2021;60(1):88-119. doi:10.1002/anie.202006648

Learn More about our Services and how can we help you with your research!

Introduction

In behavioral neuroscience, the Open Field Test (OFT) remains one of the most widely used assays to evaluate rodent models of affect, cognition, and motivation. It provides a non-invasive framework for examining how animals respond to novelty, stress, and pharmacological or environmental manipulations. Among the test’s core metrics, the percentage of time spent in the center zone offers a uniquely normalized and sensitive measure of an animal’s emotional reactivity and willingness to engage with a potentially risky environment.

This metric is calculated as the proportion of time spent in the central area of the arena—typically the inner 25%—relative to the entire session duration. By normalizing this value, researchers gain a behaviorally informative variable that is resilient to fluctuations in session length or overall movement levels. This makes it especially valuable in comparative analyses, longitudinal monitoring, and cross-model validation.

Unlike raw center duration, which can be affected by trial design inconsistencies, the percentage-based measure enables clearer comparisons across animals, treatments, and conditions. It plays a key role in identifying trait anxiety, avoidance behavior, risk-taking tendencies, and environmental adaptation, making it indispensable in both basic and translational research contexts.

Whereas simple center duration provides absolute time, the percentage-based metric introduces greater interpretability and reproducibility, especially when comparing different animal models, treatment conditions, or experimental setups. It is particularly effective for quantifying avoidance behaviors, risk assessment strategies, and trait anxiety profiles in both acute and longitudinal designs.

What Does Percentage of Time in the Centre Measure?

This metric reflects the relative amount of time an animal chooses to spend in the open, exposed portion of the arena—typically defined as the inner 25% of a square or circular enclosure. Because rodents innately prefer the periphery (thigmotaxis), time in the center is inversely associated with anxiety-like behavior. As such, this percentage is considered a sensitive, normalized index of:

  • Exploratory drive vs. risk aversion: High center time reflects an animal’s willingness to engage with uncertain or exposed environments, often indicative of lower anxiety and a stronger intrinsic drive to explore. These animals are more likely to exhibit flexible, information-gathering behaviors. On the other hand, animals that spend little time in the center display a strong bias toward the safety of the perimeter, indicative of a defensive behavioral state or trait-level risk aversion. This dichotomy helps distinguish adaptive exploration from fear-driven avoidance.

  • Emotional reactivity: Fluctuations in center time percentage serve as a sensitive behavioral proxy for changes in emotional state. In stress-prone or trauma-exposed animals, decreased center engagement may reflect hypervigilance or fear generalization, while a sudden increase might indicate emotional blunting or impaired threat appraisal. The metric is also responsive to acute stressors, environmental perturbations, or pharmacological interventions that impact affective regulation.

  • Behavioral confidence and adaptation: Repeated exposure to the same environment typically leads to reduced novelty-induced anxiety and increased behavioral flexibility. A rising trend in center time percentage across trials suggests successful habituation, reduced threat perception, and greater confidence in navigating open spaces. Conversely, a stable or declining trend may indicate behavioral rigidity or chronic stress effects.

  • Pharmacological or genetic modulation: The percentage of time in the center is widely used to evaluate the effects of pharmacological treatments and genetic modifications that influence anxiety-related circuits. Anxiolytic agents—including benzodiazepines, SSRIs, and cannabinoid agonists—reliably increase center occupancy, providing a robust behavioral endpoint in preclinical drug trials. Similarly, genetic models targeting serotonin receptors, GABAergic tone, or HPA axis function often show distinct patterns of center preference, offering translational insights into psychiatric vulnerability and resilience.

Critically, because this metric is normalized by session duration, it accommodates variability in activity levels or testing conditions. This makes it especially suitable for comparing across individuals, treatment groups, or timepoints in longitudinal studies.

A high percentage of center time indicates reduced anxiety, increased novelty-seeking, or pharmacological modulation (e.g., anxiolysis). Conversely, a low percentage suggests emotional inhibition, behavioral avoidance, or contextual hypervigilance. reduced anxiety, increased novelty-seeking, or pharmacological modulation (e.g., anxiolysis). Conversely, a low percentage suggests emotional inhibition, behavioral avoidance, or contextual hypervigilance.

Behavioral Significance and Neuroscientific Context

1. Emotional State and Trait Anxiety

The percentage of center time is one of the most direct, unconditioned readouts of anxiety-like behavior in rodents. It is frequently reduced in models of PTSD, chronic stress, or early-life adversity, where animals exhibit persistent avoidance of the center due to heightened emotional reactivity. This metric can also distinguish between acute anxiety responses and enduring trait anxiety, especially in longitudinal or developmental studies. Its normalized nature makes it ideal for comparing across cohorts with variable locomotor profiles, helping researchers detect true affective changes rather than activity-based confounds.

2. Exploration Strategies and Cognitive Engagement

Rodents that spend more time in the center zone typically exhibit broader and more flexible exploration strategies. This behavior reflects not only reduced anxiety but also cognitive engagement and environmental curiosity. High center percentage is associated with robust spatial learning, attentional scanning, and memory encoding functions, supported by coordinated activation in the prefrontal cortex, hippocampus, and basal forebrain. In contrast, reduced center engagement may signal spatial rigidity, attentional narrowing, or cognitive withdrawal, particularly in models of neurodegeneration or aging.

3. Pharmacological Responsiveness

The open field test remains one of the most widely accepted platforms for testing anxiolytic and psychotropic drugs. The percentage of center time reliably increases following administration of anxiolytic agents such as benzodiazepines, SSRIs, and GABA-A receptor agonists. This metric serves as a sensitive and reproducible endpoint in preclinical dose-finding studies, mechanistic pharmacology, and compound screening pipelines. It also aids in differentiating true anxiolytic effects from sedation or motor suppression by integrating with other behavioral parameters like distance traveled and entry count (Prut & Belzung, 2003).

4. Sex Differences and Hormonal Modulation

Sex-based differences in emotional regulation often manifest in open field behavior, with female rodents generally exhibiting higher variability in center zone metrics due to hormonal cycling. For example, estrogen has been shown to facilitate exploratory behavior and increase center occupancy, while progesterone and stress-induced corticosterone often reduce it. Studies involving gonadectomy, hormone replacement, or sex-specific genetic knockouts use this metric to quantify the impact of endocrine factors on anxiety and exploratory behavior. As such, it remains a vital tool for dissecting sex-dependent neurobehavioral dynamics.
The percentage of center time is one of the most direct, unconditioned readouts of anxiety-like behavior in rodents. It is frequently reduced in models of PTSD, chronic stress, or early-life adversity. Because it is normalized, this metric is especially helpful for distinguishing between genuine avoidance and low general activity.

Methodological Considerations

  • Zone Definition: Accurately defining the center zone is critical for reliable and reproducible data. In most open field arenas, the center zone constitutes approximately 25% of the total area, centrally located and evenly distanced from the walls. Software-based segmentation tools enhance precision and ensure consistency across trials and experiments. Deviations in zone parameters—whether due to arena geometry or tracking inconsistencies—can result in skewed data, especially when calculating percentages.

     

  • Trial Duration: Trials typically last between 5 to 10 minutes. The percentage of time in the center must be normalized to total trial duration to maintain comparability across animals and experimental groups. Longer trials may lead to fatigue, boredom, or habituation effects that artificially reduce exploratory behavior, while overly short trials may not capture full behavioral repertoires or response to novel stimuli.

     

  • Handling and Habituation: Variability in pre-test handling can introduce confounds, particularly through stress-induced hypoactivity or hyperactivity. Standardized handling routines—including gentle, consistent human interaction in the days leading up to testing—reduce variability. Habituation to the testing room and apparatus prior to data collection helps animals engage in more representative exploratory behavior, minimizing novelty-induced freezing or erratic movement.

     

  • Tracking Accuracy: High-resolution tracking systems should be validated for accurate, real-time detection of full-body center entries and sustained occupancy. The system should distinguish between full zone occupancy and transient overlaps or partial body entries that do not reflect true exploratory behavior. Poor tracking fidelity or lag can produce significant measurement error in percentage calculations.

     

  • Environmental Control: Uniformity in environmental conditions is essential. Lighting should be evenly diffused to avoid shadow bias, and noise should be minimized to prevent stress-induced variability. The arena must be cleaned between trials using odor-neutral solutions to eliminate scent trails or pheromone cues that may affect zone preference. Any variation in these conditions can introduce systematic bias in center zone behavior. Use consistent definitions of the center zone (commonly 25% of total area) to allow valid comparisons. Software-based segmentation enhances spatial precision.

Interpretation with Complementary Metrics

Temporal Dynamics of Center Occupancy

Evaluating how center time evolves across the duration of a session—divided into early, middle, and late thirds—provides insight into behavioral transitions and adaptive responses. Animals may begin by avoiding the center, only to gradually increase center time as they habituate to the environment. Conversely, persistently low center time across the session can signal prolonged anxiety, fear generalization, or a trait-like avoidance phenotype.

Cross-Paradigm Correlation

To validate the significance of center time percentage, it should be examined alongside results from other anxiety-related tests such as the Elevated Plus Maze, Light-Dark Box, or Novelty Suppressed Feeding. Concordance across paradigms supports the reliability of center time as a trait marker, while discordance may indicate task-specific reactivity or behavioral dissociation.

Behavioral Microstructure Analysis

When paired with high-resolution scoring of behavioral events such as rearing, grooming, defecation, or immobility, center time offers a richer view of the animal’s internal state. For example, an animal that spends substantial time in the center while grooming may be coping with mild stress, while another that remains immobile in the periphery may be experiencing more severe anxiety. Microstructure analysis aids in decoding the complexity behind spatial behavior.

Inter-individual Variability and Subgroup Classification

Animals naturally vary in their exploratory style. By analyzing percentage of center time across subjects, researchers can identify behavioral subgroups—such as consistently bold individuals who frequently explore the center versus cautious animals that remain along the periphery. These classifications can be used to examine predictors of drug response, resilience to stress, or vulnerability to neuropsychiatric disorders.

Machine Learning-Based Behavioral Clustering

In studies with large cohorts or multiple behavioral variables, machine learning techniques such as hierarchical clustering or principal component analysis can incorporate center time percentage to discover novel phenotypic groupings. These data-driven approaches help uncover latent dimensions of behavior that may not be visible through univariate analyses alone.

Total Distance Traveled

Total locomotion helps contextualize center time. Low percentage values in animals with minimal movement may reflect sedation or fatigue, while similar values in high-mobility subjects suggest deliberate avoidance. This metric helps distinguish emotional versus motor causes of low center engagement.

Number of Center Entries

This measure indicates how often the animal initiates exploration of the center zone. When combined with percentage of time, it differentiates between frequent but brief visits (indicative of anxiety or impulsivity) versus fewer but sustained center engagements (suggesting comfort and behavioral confidence).

Latency to First Center Entry

The delay before the first center entry reflects initial threat appraisal. Longer latencies may be associated with heightened fear or low motivation, while shorter latencies are typically linked to exploratory drive or low anxiety.

Thigmotaxis Time

Time spent hugging the walls offers a spatial counterbalance to center metrics. High thigmotaxis and low center time jointly support an interpretation of strong avoidance behavior. This inverse relationship helps triangulate affective and motivational states.

Applications in Translational Research

  • Drug Discovery: The percentage of center time is a key behavioral endpoint in the development and screening of anxiolytic, antidepressant, and antipsychotic medications. Its sensitivity to pharmacological modulation makes it particularly valuable in dose-response assessments and in distinguishing therapeutic effects from sedative or locomotor confounds. Repeated trials can also help assess drug tolerance and chronic efficacy over time.
  • Genetic and Neurodevelopmental Modeling: In transgenic and knockout models, altered center percentage provides a behavioral signature of neurodevelopmental abnormalities. This is particularly relevant in the study of autism spectrum disorders, ADHD, fragile X syndrome, and schizophrenia, where subjects often exhibit heightened anxiety, reduced flexibility, or altered environmental engagement.
  • Hormonal and Sex-Based Research: The metric is highly responsive to hormonal fluctuations, including estrous cycle phases, gonadectomy, and hormone replacement therapies. It supports investigations into sex differences in stress reactivity and the behavioral consequences of endocrine disorders or interventions.
  • Environmental Enrichment and Deprivation: Housing conditions significantly influence anxiety-like behavior and exploratory motivation. Animals raised in enriched environments typically show increased center time, indicative of reduced stress and greater behavioral plasticity. Conversely, socially isolated or stimulus-deprived animals often show strong center avoidance.
  • Behavioral Biomarker Development: As a robust and reproducible readout, center time percentage can serve as a behavioral biomarker in longitudinal and interventional studies. It is increasingly used to identify early signs of affective dysregulation or to track the efficacy of neuromodulatory treatments such as optogenetics, chemogenetics, or deep brain stimulation.
  • Personalized Preclinical Models: This measure supports behavioral stratification, allowing researchers to identify high-anxiety or low-anxiety phenotypes before treatment. This enables within-group comparisons and enhances statistical power by accounting for pre-existing behavioral variation. Used to screen anxiolytic agents and distinguish between compounds with sedative vs. anxiolytic profiles.

Enhancing Research Outcomes with Percentage-Based Analysis

By expressing center zone activity as a proportion of total trial time, researchers gain a metric that is resistant to session variability and more readily comparable across time, treatment, and model conditions. This normalized measure enhances reproducibility and statistical power, particularly in multi-cohort or cross-laboratory designs.

For experimental designs aimed at assessing anxiety, exploratory strategy, or affective state, the percentage of time spent in the center offers one of the most robust and interpretable measures available in the Open Field Test.

Explore high-resolution tracking solutions and open field platforms at

References

  • Prut, L., & Belzung, C. (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology, 463(1–3), 3–33.
  • Seibenhener, M. L., & Wooten, M. C. (2015). Use of the open field maze to measure locomotor and anxiety-like behavior in mice. Journal of Visualized Experiments, (96), e52434.
  • Crawley, J. N. (2007). What’s Wrong With My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice. Wiley-Liss.
  • Carola, V., D’Olimpio, F., Brunamonti, E., Mangia, F., & Renzi, P. (2002). Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behavior in inbred mice. Behavioral Brain Research, 134(1–2), 49–57.

Written by researchers, for researchers — powered by Conduct Science.